Page last updated: 2024-09-03

stachydrine and Astrocytoma

stachydrine has been researched along with Astrocytoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Liu, Y; Luo, Y; Wei, S; Zou, Q	1

Other Studies

1 other study(ies) available for stachydrine and Astrocytoma

Article	Year
Stachydrine suppresses viability & migration of astrocytoma cells via CXCR4/ERK & CXCR4/Akt pathway activity. Future oncology (London, England), 2018, Volume: 14, Issue:15 Topics: Adolescent; Antineoplastic Agents; Apoptosis; Astrocytoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Drug Evaluation, Preclinical; G1 Phase Cell Cycle Checkpoints; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Proline; Proto-Oncogene Proteins c-akt; Receptors, CXCR4	2018

Article

Year

Stachydrine suppresses viability & migration of astrocytoma cells via CXCR4/ERK & CXCR4/Akt pathway activity.

Future oncology (London, England), 2018, Volume: 14, Issue:15

Topics: Adolescent; Antineoplastic Agents; Apoptosis; Astrocytoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Drug Evaluation, Preclinical; G1 Phase Cell Cycle Checkpoints; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Proline; Proto-Oncogene Proteins c-akt; Receptors, CXCR4

2018